Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease

Biomarkers have been proposed as surrogate treatment targets for the management of inflammatory bowel disease (IBD); however, their relationship with IBD-related complications remains unclear. This study investigated the utility of neutrophil biomarkers fecal calprotectin (fCal) and fecal myeloperox...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Inflammatory bowel diseases 2025-01, Vol.31 (1), p.28-36
Hauptverfasser:	Swaminathan, A, Borichevsky, G M, Frampton, C M, Day, A S, Hampton, M B, Kettle, A J, Gearry, R B
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!